Prw Wealth Management LLC Neurocrine Biosciences Inc Call Options Transaction History
Prw Wealth Management LLC
- $263 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
637Shares Held
93.8MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.13 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.5 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$773 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$386 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$280 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...